Phase 2 Trial of Nab-Paclitaxel Plus Carboplatin for Advanced NSCLC in Patients at Risk of Bleeding From VEGF Directed Therapies
Year: 2014
Type: article
Authors: E.M. Bertino, T.M. Williams, K. Shilo, M.A. Villalona-Calero, G.S. Phillips, X. Mo, G.A. Otterson
Institution: The Ohio State University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1991828019
